Program: MCDC
Solicitation Number: MCDC-RPP-24-01
Customer: JPEO-CBRND-EB
Release Date: 11/06/23
Submission Deadline: 12/04/23 12pm ET
Description: The Joint Program Executive Office for Chemical, Biological, Radioactive, and Nuclear Defense – Enabling Biotechnologies (JPEO-CBRND-EB) program office has been established to implement comprehensive and integrated systems to rapidly discover, develop, manufacture, test and deliver Medical Countermeasures (MCM) for emergency use in response to meet the requirements of the Warfighter and as well as broader national requirements. The goal of this project is to mature and implement a rapid response MCM capability for prophylaxis (and potentially treatment) for biological, toxin, and/or chemical threats using in vivo delivered nucleic acid (DNA or RNA) to express monoclonal antibodies at protective/therapeutic serum concentrations in operationally relevant timeframes which are described below.
active_solicitations
solicitation_program: MCDC
solicitation_number: MCDC-RPP-24-01
solicitation_customer: JPEO-CBRND-EB
solicitation_release_date: 11/06/23
solicitation_submission_deadline: 12/04/23 12pm ET
solicitation_description: The Joint Program Executive Office for Chemical, Biological, Radioactive, and Nuclear Defense – Enabling Biotechnologies (JPEO-CBRND-EB) program office has been established to implement comprehensive and integrated systems to rapidly discover, develop, manufacture, test and deliver Medical Countermeasures (MCM) for emergency use in response to meet the requirements of the Warfighter and as well as broader national requirements. The goal of this project is to mature and implement a rapid response MCM capability for prophylaxis (and potentially treatment) for biological, toxin, and/or chemical threats using in vivo delivered nucleic acid (DNA or RNA) to express monoclonal antibodies at protective/therapeutic serum concentrations in operationally relevant timeframes which are described below.
solicitation_url: https://www.medcbrn.org/solicitations/
